Skip to main content

Table 7 Risk factors for critical patient-related adverse events during intra-hospital transport

From: High incidence of adverse events during intra-hospital transport of critically ill patients and new related risk factors: a prospective, multicenter study in China

Variable

Univariate analysis

Multivariate analysis

OR (95 % CI)

P value

OR (95 % CI)

P value

Patient characteristics

 Age, yr

1.00 (0.99–1.01)

0.71

NT

 

 Sex

0.70 (0.46–1.08)

0.10

NT

 

 Weight, kg

1.03 (1.01–1.04)

0.00*

  

   < 65

Reference

–

Reference

–

   ≥ 65

1.95 (1.30–2.94)

0.00*

1.55 (0.95–2.54)

0.08

 ICU admission type

0.95 (0.76–1.19)

0.67

NT

 

Clinical characteristics before transport

 APACHE II score

1.66 (1.29–2.14)

0.00*

  

   ≤ 11

Reference

–

Reference

–

  12–19

1.66 (1.01–2.74)

0.04*

1.44 (0.79–2.63)

0.23

   ≥ 20

2.75 (1.66–4.57)

0.00*

2.49 (1.23–5.03)

0.01*

 Glasgow Coma Scale score

0.76 (0.60–0.96)

0.02*

  

  15

Reference

–

Reference

–

  9–14

0.93 (0.53–1.64)

0.80

0.67 (0.33–1.38)

0.28

   ≤ 8

1.82 (1.14–2.91)

0.01*

0.89 (0.46–1.74)

0.74

 Artificial airway

1.38 (0.92–2.07)

0.12

NT

 

 Ventilation

1.48 (0.99–2.20)

0.06

NT

 

 Number of catheter

1.28 (1.07–1.54)

0.01*

1.20 (0.95–1.51)

0.13

 Arterial blood gas analysis

    

  pH

  

NT

 

   7.35–7.45

Reference

–

  

    < 7.35 or >7.45

1.03 (0.69–1.54)

0.88

  

  PaO2, mmHg

0.99 (0.99–1.00)

0.00*

  

    ≥ 80

Reference

–

Reference

–

    < 80

2.49 (1.61–3.86)

0.00*

2.26 (1.31–3.91)

0.00*

  PaCO2, mmHg

  

NT

 

   35–45

Reference

–

  

    < 35 or >45

1.36 (0.91–2.02)

0.13

  

  Bicarbonate level, mmol/L

  

NT

 

   22–27

Reference

–

  

    < 22 or >27

1.28 (0.86–1.92)

0.23

  

  Lactate level, mmol/L

1.87 (1.51–2.33)

0.00*

  

    < 2

Reference

–

  

    ≥ 2

2.82 (1.77–4.49)

0.00*

3.12 (1.75–5.58)

0.00*

  Glucose level, mmol/L

    

   4.0–10.0

Reference

–

  

    < 4 or >10

2.24 (1.43–3.50)

0.00*

1.80 (1.05–3.08)

0.03*

 Vital signs

    

  SBP, mmHg

  

NT

 

   90–150

Reference

–

  

    < 90 or >150

1.10 (0.62–1.95)

0.74

  

  DBP, mmHg

1.00 (0.98–1.01)

0.64

NT

 

  MAP, mmHg

1.00 (0.99–1.02)

0.95

NT

 

  Heart rate

    

   50–110

Reference

–

  

    < 50 or >110

4.53 (2.76–7.42)

0.00*

2.97 (1.66–5.32)

0.00*

  Respiratory rate

    

   12–25

Reference

–

  

    < 12 or >25

3.06 (1.92–4.89)

0.00*

2.45 (1.39–4.33)

0.00*

  Pulse oximetry

0.84 (0.78–0.91)

0.00*

  

    ≥ 95

Reference

–

  

    < 95

3.56 (1.94–6.52)

0.00*

2.79 (1.31–5.95)

0.01*

 Analgesia

1.34 (0.78–2.30)

0.28

NT

 

 Sedation

1.96 (1.25–3.09)

0.00*

1.87 (1.07–3.29)

0.03*

 Vasoactive drug support

1.51 (0.96–2.37)

0.07

NT

 

Transport characteristics

 Analgesia

0.90 (0.47–1.76)

0.76

NT

 

 Sedation

1.27 (0.77–2.10)

0.36

NT

 

 Vasoactive drug support

1.76 (1.10–2.83)

0.02*

1.63 (0.92–2.88)

0.10

 Emergency transport

1.54 (1.33–1.89)

0.01*

1.26 (0.68–2.35)

0.47

 Multiple IHTs of one patient

0.84 (0.54–1.31)

0.45

NT

 

 Night transport

0.83 (0.37–1.87)

0.65

NT

 

 Transport duration, minutes

0.99 (0.97–1.01)

0.18

NT

 
  1. APACHE Acute Physiology and Chronic Health Evaluation, PaO 2 partial pressure of oxygen in arterial blood, PaCO 2 partial pressure of carbon dioxide in arterial blood, SBP Systolic blood pressure, DBP diastolic blood pressure, MAP mean arterial pressure, NT not tested, OR odds ratio, CI confidence interval
  2. *P < 0.05